These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30451169)

  • 1. Management of central serous chorioretinopathy: Expert panel discussion.
    Chhablani J; Anantharaman G; Behar-Cohen F; Boon C; Manayath G; Singh R
    Indian J Ophthalmol; 2018 Dec; 66(12):1700-1703. PubMed ID: 30451169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and Therapeutic Challenges.
    La Spina C; Modorati GM; Bandello F; Querques G; Roberts P; Fawzi AA
    Retina; 2018 Feb; 38(2):432-437. PubMed ID: 28272282
    [No Abstract]   [Full Text] [Related]  

  • 3. Central Serous Chorioretinopathy.
    Daruich A; Matet A; Behar-Cohen F
    Dev Ophthalmol; 2017; 58():27-38. PubMed ID: 28351043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Masqueraders of central serous chorioretinopathy.
    Sahoo NK; Singh SR; Rajendran A; Shukla D; Chhablani J
    Surv Ophthalmol; 2019; 64(1):30-44. PubMed ID: 30243734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrepancy in current central serous chorioretinopathy classification.
    Singh SR; Matet A; van Dijk EHC; Daruich A; Fauser S; Yzer S; Peiretti E; Sivaprasad S; Lotery AJ; Boon CJF; Behar-Cohen F; Freund KB; Chhablani J
    Br J Ophthalmol; 2019 Jun; 103(6):737-742. PubMed ID: 30002069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dark and white lesions observed in central serous chorioretinopathy on optical coherence tomography angiography.
    De Bats F; Cornut PL; Wolff B; Kodjikian L; Mauget-Faÿsse M
    Eur J Ophthalmol; 2018 Jul; 28(4):446-453. PubMed ID: 29554817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute lupus choroidopathy: multimodal imaging and differential diagnosis from central serous chorioretinopathy.
    Hasanreisoglu M; Gulpinar Ikiz GD; Kucuk H; Varan O; Ozdek S
    Int Ophthalmol; 2018 Feb; 38(1):369-374. PubMed ID: 28050729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of secondary choroidal neovascularization in chronic central serous chorioretinopathy by swept source-optical coherence tomography angiography.
    Stattin M; Ahmed D; Forster J; Glittenberg C; Herrmann M; Krebs I; Ansari-Shahrezaei S
    Acta Ophthalmol; 2019 Feb; 97(1):e135-e136. PubMed ID: 30284407
    [No Abstract]   [Full Text] [Related]  

  • 9. Leopard-Spot Subretinal Deposits in Central Serous Chorioretinopathy.
    Marchese A; Miserocchi E; Modorati G; Querques G; Bandello F
    Retina; 2018 Jul; 38(7):e53-e54. PubMed ID: 29697592
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of Choroidal Neovascularization in Central Serous Chorioretinopathy Using Optical Coherence Tomographic Angiography.
    Weng S; Mao L; Yu S; Gong Y; Cheng L; Chen X
    Ophthalmologica; 2016; 236(2):114-21. PubMed ID: 27562525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between the central serous chorioretinopathy, choroidal thickness, and serum hormone levels.
    Çiloğlu E; Unal F; Dogan NC
    Graefes Arch Clin Exp Ophthalmol; 2018 Jun; 256(6):1111-1116. PubMed ID: 29671064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Photodynamic Therapy on Optical Coherence Tomography Angiography in Eyes with Chronic Central Serous Chorioretinopathy.
    Xu Y; Su Y; Li L; Qi H; Zheng H; Chen C
    Ophthalmologica; 2017; 237(3):167-172. PubMed ID: 28171871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FUNDUS AUTOFLUORESCENCE LIFETIMES AND CENTRAL SEROUS CHORIORETINOPATHY.
    Dysli C; Berger L; Wolf S; Zinkernagel MS
    Retina; 2017 Nov; 37(11):2151-2161. PubMed ID: 28099314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central Serous Chorioretinopathy Following Intravitreal Dexamethasone Implant.
    Noh GM; Nam KY; Lee SU; Lee SJ
    Korean J Ophthalmol; 2019 Aug; 33(4):392-394. PubMed ID: 31389218
    [No Abstract]   [Full Text] [Related]  

  • 15. FAMILIAL CENTRAL SEROUS CHORIORETINOPATHY.
    van Dijk EHC; Schellevis RL; Breukink MB; Mohabati D; Dijkman G; Keunen JEE; Yzer S; den Hollander AI; Hoyng CB; de Jong EK; Boon CJF
    Retina; 2019 Feb; 39(2):398-407. PubMed ID: 29190234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macular ganglion cell complex thickness in acute and chronic central serous chorioretinopathy.
    Demirok G; Kocamaz F; Topalak Y; Altay Y; Sengun A
    Int Ophthalmol; 2017 Apr; 37(2):409-416. PubMed ID: 27324370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can Hypothyroidism Cause Acute Central Serous Chorioretinopathy?
    Ulaş F; Uyar E; Tekçe H; Çelebi S
    Semin Ophthalmol; 2019; 34(7-8):533-540. PubMed ID: 31646925
    [No Abstract]   [Full Text] [Related]  

  • 18. Subthreshold Micropulse Laser Photocoagulation in the Management of Central Serous Chorioretinopathy.
    Ezuddin NS; Lanza NL; Weng CY
    Int Ophthalmol Clin; 2016; 56(4):165-74. PubMed ID: 27575766
    [No Abstract]   [Full Text] [Related]  

  • 19. Is Pachychoroid Serous Retinopathy a Better Name to Describe the Features of Central Serous Chorioretinopathy?
    Ersoz MG; Demirel S; Iovino C; Chhablani J; Sarraf D
    Retina; 2024 Sep; 44(9):1475-1477. PubMed ID: 39024659
    [No Abstract]   [Full Text] [Related]  

  • 20. Central Serous Chorioretinopathy Associated With Fingolimod Treatment.
    Khimani KS; Foroozan R
    J Neuroophthalmol; 2018 Sep; 38(3):337-338. PubMed ID: 29140860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.